Efficacy and safety of high and low dose recombinant human erythropoietin on neurodevelopment of premature infants

A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants

(2020) Sandra E. Juul et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of early parenteral iron combined erythropoietin in preterm infants

(2017) Linxia Qiao et al.   MEDICINE

Recombinant human erythropoietin improves neurological outcomes in very preterm infants

(2016) Juan Song et al.   ANNALS OF NEUROLOGY

Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants

(2015) Jean-Claude Fauchère et al.   JOURNAL OF PEDIATRICS

Association Between Early Administration of High-Dose Erythropoietin in Preterm Infants and Brain MRI Abnormality at Term-Equivalent Age

(2014) Russia Ha-Vinh Leuchter et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cognitive Outcomes of Preterm Infants Randomized to Darbepoetin, Erythropoietin, or Placebo

(2014) R. K. Ohls et al.   PEDIATRICS

Short-term effects of erythropoietin on neurodevelopment in infants with cerebral palsy: A pilot study

(2013) Hee Song Lee et al.   BRAIN & DEVELOPMENT

Umbilical Cord Blood Therapy Potentiated with Erythropoietin for Children with Cerebral Palsy: A Double-blind, Randomized, Placebo-Controlled Trial

(2012) Kyunghoon Min et al.   STEM CELLS

Erythropoietin improves neurodevelopmental outcome of extremely preterm infants

(2010) Achim-Peter Neubauer et al.   ANNALS OF NEUROLOGY